{
    "organizations": [],
    "uuid": "db07d6af1c492a118af42ff8f518a30362379d79",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cytori-therapeutics-co-met-with-us/brief-cytori-therapeutics-co-met-with-u-s-fda-to-discuss-outcome-of-star-clinical-trial-idUSFWN1QY0Z7",
    "ord_in_thread": 0,
    "title": "BRIEF-Cytori Therapeutics - Co Met With U.S. FDA To Discuss Outcome Of Star Clinical Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 16, 2018 / 9:15 PM / in 6 minutes BRIEF-Cytori Therapeutics - Co Met With U.S. FDA To Discuss Outcome Of Star Clinical Trial Reuters Staff 1 Min Read March 16 (Reuters) - Cytori Therapeutics Inc: * CYTORI THERAPEUTICS - ON MARCH 1, CO MET WITH U.S. FDA TO DISCUSS OUTCOME OF STAR CLINICAL TRIAL AND COâ€™S PLANS FOR HABEO CELL THERAPY - SEC FILING * CYTORI THERAPEUTICS-INTENDS TO FINALIZE & PURSUE ADDITIONAL DIALOGUE WITH FDA TO CLARIFY PARAMETERS OF FOLLOW-ON CLINICAL TRIAL OF HABEO CELL THERAPY Source text ( bit.ly/2tSzb9l ) Further company coverage: (Reuters.Brief@thomsonreuters.com)",
    "published": "2018-03-16T23:15:00.000+02:00",
    "crawled": "2018-03-16T23:27:32.068+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "minute",
        "therapeutic",
        "co",
        "met",
        "fda",
        "discus",
        "outcome",
        "star",
        "clinical",
        "trial",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "cytori",
        "therapeutic",
        "inc",
        "cytori",
        "therapeutic",
        "march",
        "co",
        "met",
        "fda",
        "discus",
        "outcome",
        "star",
        "clinical",
        "trial",
        "co",
        "plan",
        "habeo",
        "cell",
        "therapy",
        "sec",
        "filing",
        "cytori",
        "finalize",
        "pursue",
        "additional",
        "dialogue",
        "fda",
        "clarify",
        "parameter",
        "clinical",
        "trial",
        "habeo",
        "cell",
        "therapy",
        "source",
        "text",
        "company",
        "coverage"
    ]
}